Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas W Morrell

Showing results (161-170 of 278) with videos related to

Pageof 28
Sort By:
American Journal of Respiratory and Critical Care Medicine|August 27, 2011
A novel murine model of severe pulmonary arterial hypertensionLoredana Ciuclan, Olivier Bonneau, Martin Hussey, et al.
Hypertension (Dallas, Tex. : 1979)|April 16, 2014
Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA/programmed cell death 4/caspase-3 axisKevin White, Yvonne Dempsie, Paola Caruso, et al.
The European Respiratory Journal|October 27, 2022
Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAHChristina A Eichstaedt, Catharina Belge, Wendy K Chung, et al.
Circulation|March 25, 2014
Proteomic analysis implicates translationally controlled tumor protein as a novel mediator of occlusive vascular remodeling in pulmonary arterial hypertensionJessie R Lavoie, Mark L Ormiston, Carol Perez-Iratxeta, et al.
The Journal of Clinical Investigation|April 3, 2008
An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertensionGeorg Hansmann, Vinicio A de Jesus Perez, Tero-Pekka Alastalo, et al.
The European Respiratory Journal|April 18, 2020
Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?Eleni Sofianopoulou, Colin Church, Gerry Coghlan, et al.
Thorax|February 9, 2007
Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertensionJay Suntharalingam, Rajiv D Machado, Linda D Sharples, et al.
Pulmonary Circulation|May 11, 2013
Anticipated classes of new medications and molecular targets for pulmonary arterial hypertensionNicholas W Morrell, Stephen L Archer, Albert Defelice, et al.
Vascular Pharmacology|June 20, 2024
Fluorinated perhexiline derivative attenuates vascular proliferation in pulmonary arterial hypertension smooth muscle cellsKayleigh Griffiths, Roger J Grand, Ian Horan, et al.
Thorax|February 8, 2011
Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertensionElaine Soon, Carmen M Treacy, Mark R Toshner, et al.
Pageof 28

Showing results (161-170 of 278) with videos related to

Sort By:
Pageof 28
American Journal of Respiratory and Critical Care Medicine|August 27, 2011
A novel murine model of severe pulmonary arterial hypertensionLoredana Ciuclan, Olivier Bonneau, Martin Hussey, et al.
Hypertension (Dallas, Tex. : 1979)|April 16, 2014
Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA/programmed cell death 4/caspase-3 axisKevin White, Yvonne Dempsie, Paola Caruso, et al.
The European Respiratory Journal|October 27, 2022
Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAHChristina A Eichstaedt, Catharina Belge, Wendy K Chung, et al.
Circulation|March 25, 2014
Proteomic analysis implicates translationally controlled tumor protein as a novel mediator of occlusive vascular remodeling in pulmonary arterial hypertensionJessie R Lavoie, Mark L Ormiston, Carol Perez-Iratxeta, et al.
The Journal of Clinical Investigation|April 3, 2008
An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertensionGeorg Hansmann, Vinicio A de Jesus Perez, Tero-Pekka Alastalo, et al.
The European Respiratory Journal|April 18, 2020
Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?Eleni Sofianopoulou, Colin Church, Gerry Coghlan, et al.
Thorax|February 9, 2007
Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertensionJay Suntharalingam, Rajiv D Machado, Linda D Sharples, et al.
Pulmonary Circulation|May 11, 2013
Anticipated classes of new medications and molecular targets for pulmonary arterial hypertensionNicholas W Morrell, Stephen L Archer, Albert Defelice, et al.
Vascular Pharmacology|June 20, 2024
Fluorinated perhexiline derivative attenuates vascular proliferation in pulmonary arterial hypertension smooth muscle cellsKayleigh Griffiths, Roger J Grand, Ian Horan, et al.
Thorax|February 8, 2011
Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertensionElaine Soon, Carmen M Treacy, Mark R Toshner, et al.
Pageof 28